Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Technology Stocks : Barringer technology (barr) -- Ignore unavailable to you. Want to Upgrade?

To: Savant who wrote (650)	3/9/2001 9:56:35 AM
From: Savant	Respond to of 652

Barringer Technologies Inc. Announces Definitive Merger Agreement WARREN, N.J., Mar 9, 2001 (BUSINESS WIRE) -- Barringer Technologies Inc. (Nasdaq: BARR), one of the world's leading providers of trace drug and explosive detection equipment, today announced that it has entered into a definitive agreement with Smiths Group plc ("Smiths") under which Smiths would acquire all the outstanding shares of Barringer for $11.05 per share in cash. The transaction values the equity of Barringer Technologies at approximately $87 million. The $11.05 acquisition price per share represents a 17% premium to the average closing stock price for the company over the last 30 trading days. The transaction, which has been approved by the Boards of Directors of both companies is subject to approval by Barringer stockholders and customary closing conditions and is expected to close in the second quarter of this year. Stanley Binder, Chairman and Chief Executive Officer of Barringer stated: " The combination of Smiths position as one of the world's leading specialists in nuclear, biological and chemical detection equipment with Barringer's world leadership position in drug and explosives detection equipment will result in a very strong vehicle for continued growth." Barringer also announced today in a separate release the results for the fourth quarter and full year ended December 31, 2000. Headquartered in Warren, New Jersey, Barringer Technologies Inc. is one of the world's leading providers of trace detection equipment for drug, explosive, and chemical detection for security and industrial applications. The Sabre 2000(R) and the IONSCAN(R) are the Company's proprietary trace particle drug and explosive detection units. Smiths is a global business with market-leading positions in each of its four operating businesses: advanced aerospace systems; mechanical and polymer seals; medical devices and critical care equipment; and specialized industrial products for interconnect & air movement applications. William Blair & Company L.L.C. advised Barringer Technologies in this transaction.